Valuation: GKB Ophthalmics Limited

Market Cap 265M 2.77M 2.43M 2.24M 2.07M 3.92M 3.99M 26.75M 10.5M 130M 10.42M 10.19M 448M P/E 2024
-15.6x
P/E 2025 -4.32x
Enterprise Value 280M 2.94M 2.57M 2.37M 2.19M 4.15M 4.22M 28.32M 11.12M 138M 11.03M 10.79M 475M EV / Sales 2024
0.43x
EV / Sales 2025 0.29x
Free-Float
23.1%
Yield 2024 *
-
Yield 2025 -
05-27 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
14/08/25 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/02/25 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/11/24 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/08/24 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
30/05/24 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
19/03/24 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
14/02/24 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
14/11/23 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
11/08/23 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
1 day-1.61%
1 week-4.93%
Current month-6.67%
1 month-3.23%
3 months-19.84%
6 months+15.43%
Current year+17.10%
1 week 58.3
Extreme 58.3
62.85
1 month 58.3
Extreme 58.3
65.22
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
91.7
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 09/12/1981
Director of Finance/CFO - 31/03/2019
Chief Administrative Officer 62 31/05/2024
Director TitleAgeSince
Chairman 84 09/12/1981
Director/Board Member 57 23/07/1996
Director/Board Member 68 19/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
-1.61%-4.93%-21.17%-33.88% 3.17M
-0.15%-0.46%-31.44%+0.23% 90.08B
+0.74%-1.09%-23.60%-25.03% 32.91B
-0.45%-4.72%-7.82%-26.25% 13.79B
-0.42%+2.00% - - 9.91B
+1.34%-11.92%-23.70%+507.65% 1.97B
+1.61%-3.34%-31.48%-66.30% 1.41B
0.00%+0.67%+25.84%+4.46% 897M
-0.59%-1.38%-37.45%-28.53% 846M
+0.67%-2.41%+44.36%-31.20% 764M
Average +0.11%-2.63%-11.83%+33.46% 15.26B
Weighted average by Cap. +0.04%-1.00%-26.51%-2.12%

Financials

2024 2025
Net sales 883M 9.25M 8.09M 7.47M 6.9M 13.08M 13.3M 89.2M 35.03M 435M 34.74M 33.99M 1.49B 1.09B 11.43M 10M 9.22M 8.52M 16.16M 16.43M 110M 43.26M 537M 42.91M 41.97M 1.85B
Net income -28.1M -295K -258K -238K -220K -417K -424K -2.84M -1.12M -13.85M -1.11M -1.08M -47.6M -70.45M -739K -646K -596K -550K -1.04M -1.06M -7.12M -2.8M -34.7M -2.77M -2.71M -119M
Net Debt -57.22M -600K -525K -484K -447K -848K -863K -5.78M -2.27M -28.19M -2.25M -2.2M -96.9M 15.59M 163K 143K 132K 122K 231K 235K 1.58M 619K 7.68M 614K 600K 26.4M
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
170
Date Price Change Volume
10/07/26 ₹60.00 -1.61% 518
09/07/26 ₹60.98 +4.60% 4
08/07/26 ₹58.30 -2.74% 520
07/07/26 ₹59.94 -0.68% 1,950
06/07/26 ₹60.35 -4.37% 1,843